Study Finds New Saliva-Based Antibody Test for SARS-CoV-2 Highly Accurate
A new saliva-based test developed by a team at Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) has been found to accurately detect the presence of antibodies to SARS-CoV-2 from small samples of saliva. More...16 Nov 2020
CRP Tracking Predicts Potential Outcome for Hospitalized COVID-19 Patients
By tracking the increase in circulating levels of the inflammatory biomarker C-reactive protein, doctors are able to predict whether newly hospitalized COVID-19 patients will suffer respiratory deterioration with the possible need for intubation. More...16 Nov 2020
Lung Ultrasound Scan Findings Can Help Identify False-Negative COVID-19 Test Results
A new study has found that the integration of lung ultrasound (LUS) with clinical evaluation is associated with increased sensitivity for the diagnosis of COVID-19 pneumonia, and may facilitate the identification of false negative SARS-CoV-2 RT-PCR results. More...13 Nov 2020
PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling
PerkinElmer, Inc.’s (Waltham, MA; USA) SARS-CoV-2 Real-time RT-PCR Assay has received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five specimens collected from individuals suspected of COVID-19 or asymptomatic individuals. More...13 Nov 2020
New COVID-19 Test That Identifies T-Cell Signature Better at Detecting Past Coronavirus Infection
New research shows that the unique properties of T cells could make a test that detects virus-specific T cells in a more effective way to assess SARS-CoV-2 exposure before antibodies arise and after they wane. More...12 Nov 2020
Qiagen and TScan Therapeutics to Jointly Develop T Cell-Based Laboratory Test for COVID-19 Immune Response
QIAGEN N.V. (Venlo, Netherlands) and TScan Therapeutics (Waltham, MA, USA) have entered into a research license and option agreement to develop T cell-based laboratory tests for detecting prior exposure to the novel coronavirus, SARS-CoV-2, using discoveries from TScan’s high-throughput TCR/Target discovery platform, T-Scan. More...11 Nov 2020
Gold Member
Troponin T QC
Troponin T Quality Control
New
Troponin I Test
Quidel Triage Troponin I Test
New
High Performance Centrifuge
CO336/336R
In Other News
Stand-Alone COVID-19 Rapid POC Antigen Test Delivers Results in 10 Minutes Without Separate Analyzer
Researchers Use Physics Technology to Develop Rapid Antigen COVID-19 Test
Researchers Developing 'Lab-in-Box' Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR
Fujirebio Europe Partners with Centogene to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing
FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection
Carolina Liquid Chemistries COVID-19 Antibody Test Receives FDA EUA for Use with Fingerstick Blood Samples at POC
Highly Automated Microlab Half the Size of Credit Card Detects COVID-19 in 30 Minutes
COVID-19 Antigen Tests for Rapid Detection of SARS-CoV-2 Can Provide False Positive Results, Warns FDA
COVID-19 Test Uses DNA Nanoswitch Technology to Detect SARS-CoV-2 Virus
ORAcollect RNA Saliva Collection Device for SARS CoV-2 Granted FDA Emergency Use Authorization
New Biomimicry Control for COVID Diagnostics Improves Accuracy and Safety of Coronavirus Testing
On-the-Go SARS-CoV-2 Testing Device Being Designed for Rapid Reporting of Results
New Technology Pulls Elusive COVID-19 Marker from Blood to Better Measure Disease Severity
Randox Unveils Whole Pathogen Multiplex Controls to Support Testing for Cold, Cough and COVID-19
Global COVID-19 Diagnostics Market to Reach USD 9.94 Billion by Fourth Quarter of 2020
Non-Invasive COVID-19 Test Identifies `Breath Signatures` to Provide Almost Instant Results
World’s Fastest PCR-Based SARS-CoV-2 Test Now Available on Randox-Bosch Vivalytic POC Analyzer
Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership
Study to Examine Whether Rapid COVID-19 Antigen Tests Can Identify Infectious and Asymptomatic Individuals
Ortho Launches New VITROS SARS-CoV-2 Antigen Test for Accurate Mass-Scale Testing in Markets Accepting CE Mark
DiaSorin Launches New LIAISON SARS-CoV-2 Ag High-Throughput Antigen Test in Markets Accepting CE Mark
New Groundbreaking COVID-19 Test to Identify SARS-CoV-2 Virus Particles in Exhaled Breath Within Five Minutes
PerkinElmer’s Multianalyte SARS-CoV-2, Flu Test Receives CE Mark
